RESULTS: Results: Participating were 3 institutions and 10 surgeons. Eighty-four parents completed the survey a median of 33 days (IQR 27-40) post-surgery. More parents reported bladder spasms and hematuria in the OR group vs RALR and DxHA . Although there was no difference in maximum bladder spasm pain, duration of pain medication for spasms was longer with OR vs RALR. Most parents (87%) reported they were prepared for their child's symptoms after surgery. But 33% of OR and 36% of RALR reported spasms were more painful than expected, and 49% of OR reported hematuria was worse than expected. (Table) CONCLUSIONS: Conclusion: We found a significant difference in parental reports of bladder spasms, pain medication, and hematuria between OR, RALR, and DxHA. Although most parents said they were prepared for their child's recovery, many reported the symptoms were worse than expected. These contradictions may reflect a need for improved physician to parent communication when discussion antireflux surgery.
INTRODUCTION AND OBJECTIVES:
Infants are vulnerable to fever and require rapid diagnosis and treatment. It is difficult to find the cause of fever in infants. Urinary tract infection (UTI) is one of the most common bacterial infections in febrile infants and its prevalence is especially high in infants younger than 3 months. Delayed diagnosis and management of UTI can result in renal damage and loss of renal function. Although urine culture is the standard approach to confirm the diagnosis of UTI, it takes a long time to obtain the results. It has become clear that obesity is associated with a variety of infectious diseases, including UTI. The aim of this study was to evaluate the association between obesity and the degree of febrile UTI (fUTI) in infants with fever.
METHODS: A total of 492 patients aged <3 months were admitted to Keimyung University Dongsan Medical Center due to fever (body temperature ! 38 C) without a source between January and December 2016, and we retrospectively reviewed the medical records of 422 patients. Overweight or obese status of the patients was defined using weight-for-length (WFL) measurements. They were divided into three groups as follows; the standard (<85%), the overweight (85-95%), and the obese (!95%) groups, based on a recent report that identified obesity in young children. We compared the following clinical and laboratory variables: gender, age (days), degree of obesity, degree of inflammation at the time of admission according to the presence or absence of UTI.
RESULTS: We reviewed the data of 492 patients and excluded 70 patients. Among 422 patients (M:F[267:155; mean age[56.4 days), 102 (24.2%) patients were classified into the UTI group and 320 (75.8%) into the non-UTI group. UTI occurred more frequently in infants with obesity and they were associated with a higher grade of serum WBC count, CRP, pyuria grade, and positive urine nitrites (p<0.001, respectively).
CONCLUSIONS: We have shown that obesity has an effect on fUTI in infants < 3 months of age. If the degree of obesity is high, it can help in the early diagnosis and treatment of UTI in febrile infants <3 months of age with non-specific symptoms. Also, we should perform a close follow-up and actively consider treatment for obesity. and febrile urinary tract infection (fUTI). Change in management was defined as surgical intervention to treat symptomatic VUR or restarting CAP.
RESULTS: The median age at CAP discontinuation and median follow-up time were 20 months (IQR: 19) and 42 months (IQR: 33) respectively. Of 218 VUR patients, 105 (48%) were male and 38 (36%) circumcised. There were 135 (62%) patients with unremarkable serial US findings and 83 (38%) with hydronephrosis (HN). Patients with normal vs. abnormal US findings experienced similar rates of change in management (11% vs. 8%, p[0.7). In patients with normal US findings, those with fUTI were more likely to experience a change in management than those without (52% vs. 0%, p < 0.01). Of patients with abnormal US findings, 58/83 (70%) had low grade HN. In this group, change in management was more likely to occur in patients with fUTI vs. those without (50% vs. 2%, p <0.01). Classification of low vs. high HN did not have a significant effect on change in management (9% vs. 8%, p[1.0).
CONCLUSIONS: In 2/3 of VUR patients, US findings were unremarkable and did not impact clinical management. The driving factor for change in management was fUTI post-CAP discontinuation. Thus, asymptomatic VUR patients may not require routine follow-ups with renal US after stopping CAP. 
